omniture
logo
Search
TAIGEN BIOTECHNOLOGY
Media Room

Latest News

rss

TaiGen Successfully Completes TG-1000 Phase III Study

TAIPEI, April 17, 2024 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") announces t...

2024-04-18 11:03 1546

TaiGen Enters Exclusive License Agreement with YSP

TAIPEI, Oct. 10, 2023 /PRNewswire/ -- TaiGen Biopharmaceuticals Holdings Ltd. ("TaiGen") announces ...

2023-10-11 11:24 1655

TaiGen Partners with GPCR to develop Burixafor & Taigexyn(R)

TAIPEI, Nov. 9, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") announced tod...

2020-11-09 18:22 1795

TaiGen Announces FDA Approval of IND for Its Flu Antiviral TG-1000

TAIPEI, Taiwan, Nov. 1, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") (Taiw...

2020-11-02 07:30 1279

TaiGen filed US IND for its influenza antiviral TG-1000

TAIPEI, Taiwan, Oct. 4, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") annou...

2020-10-05 06:50 2369

TaiGen Biotechnology Out-Licensed Taigexyn (Nemonoxacin) to Luminarie Canada for Canada, Australia and New Zealand

TAIPEI, Sept. 30, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen")(Taiwan: 415...

2020-09-30 15:51 1852